The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Streamlining regulatory review in a multicenter platform trial: Opportunity to enhance patient centered care and drive innovation and efficiency.
 
Alexis Colley
No Relationships to Disclose
 
Teresa L. Helsten
No Relationships to Disclose
 
Brian Moore
No Relationships to Disclose
 
Linda Neuhauser
Stock and Other Ownership Interests - Abbvie (I); Bristol-Myers Squibb/Medarex (I); Johnson and Johnson; Merck (I)
Consulting or Advisory Role - Bayer Germany
 
Barbara Keenoy LeStage
Stock and Other Ownership Interests - Abbott Laboratories; Abbvie; Amgen; Johnson & Johnson; Novartis; Teleflex Medical; Zimmer
 
Paolo Castillo
No Relationships to Disclose
 
Maria Pitsiouni
Employment - Quantum Leap Healthcare Collaborative; Quantum Leap Healthcare Collaborative
Leadership - Quantum Leap Healthcare Collaborative; Quantum Leap Healthcare Collaborative
Research Funding - Quantum Leap Healthcare Collaborative
Travel, Accommodations, Expenses - Quantum Leap Healthcare Collaborative
 
Anthony D. Elias
Stock and Other Ownership Interests - Abbott Laboratories; Abbvie; Agilent; Alexion Pharmaceuticals; Align Oncology; Allergan; Amgen; Biogenerix; Bristol-Myers Squibb; Cigna; Exact Sciences; Gilead Sciences; Illumina; Lilly; Merck; Pfizer; United Health Group
Research Funding - Astellas Pharma (Inst); BioAtla (Inst); Deciphera (Inst); Genentech (Inst); Infinity Pharmaceuticals (Inst); Karyopharm Therapeutics (Inst); Orinove (Inst); TopAlliance BioSciences Inc (Inst); xencor (Inst)
(OPTIONAL) Uncompensated Relationships - Seiyax
 
Carla Isadora Falkson
Honoraria - Curio Science
Consulting or Advisory Role - Agendia; bioTheranostics
Speakers' Bureau - OncLive/MJH Life Sciences
Research Funding - Lilly (Inst); Oncolytics (Inst); QuantumLeap Health (Inst)
 
Alexandra Thomas
Stock and Other Ownership Interests - Bristol-Myers Squibb; Doximity; Gilead Sciences; Johnson & Johnson (I); Pfizer
Consulting or Advisory Role - BeyondSpring Pharmaceuticals; Genentech; Lilly
Research Funding - Merck (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Up-to-Date Royalties (I)
 
Claudine Isaacs
Consulting or Advisory Role - AstraZeneca/MedImmune; bioTheranostics; Genentech/Roche; Gilead Sciences; Ion Solutions; Novartis; Pfizer; Puma Biotechnology; Seagen
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb/Celgene (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Seagen (Inst); Tesaro (Inst)
Patents, Royalties, Other Intellectual Property - Elsevier - Editor of Book; McGraw Hill Publishing; UpToDate - Wolters Kluwer - Author of chapters
Other Relationship - Side-Out Foundation
 
Amy Sanders Clark
Honoraria - Siemens
Consulting or Advisory Role - Novartis
Research Funding - Lilly (Inst); Novartis (Inst); Seagen (Inst)
 
David Potter
Honoraria - Dava Oncology; Immunomedics/Gilead; OncLive Clinical Congress Consultants; Puma Biotechnology
Research Funding - Abbvie (Inst); Abbvie (Inst); ImmunoMet (Inst); Innocrin Pharma (Inst); Pfizer (Inst); Takeda Science Foundation (Inst)
Travel, Accommodations, Expenses - Immunomedics/Gilead
 
Evanthia T. Roussos Torres
Stock and Other Ownership Interests - Synaptical
 
Rita Nanda
Consulting or Advisory Role - AstraZeneca; BeyondSpring Pharmaceuticals; Cardinal Health; Fujifilm; GE Healthcare; Gilead Sciences; Infinity Pharmaceuticals; ITeos Therapeutics; Merck; OBI Pharma; OncoSec; Sanofi; Seagen
Research Funding - Arvinas (Inst); AstraZeneca (Inst); Celgene (Inst); Corcept Therapeutics (Inst); Genentech/Roche (Inst); Immunomedics (Inst); Merck (Inst); OBI Pharma (Inst); Odonate Therapeutics (Inst); OncoSec (Inst); Pfizer (Inst); Relay Therapeutics (Inst); Seagen (Inst); Sun Pharma (Inst); Taiho Oncology (Inst)
Other Relationship - G1 Therapeutics
 
Chaitali Nangia
Consulting or Advisory Role - Gilead Sciences; Menarini; Novartis; Regeneron; Sanofi
Speakers' Bureau - Merck; Novartis; Regeneron; Sanofi
Travel, Accommodations, Expenses - Gilead Sciences; Novartis; Regeneron; Sanofi
 
Laura Esserman
Consulting or Advisory Role - Blue Cross Blue Shield Association
Research Funding - Merck
Travel, Accommodations, Expenses - Blue Cross Blue Shield Association
(OPTIONAL) Uncompensated Relationships - Quantum Leap Healthcare Collaborative